Pharmas continue this R&D this year too

New drug development will continue.

Major Korean pharmaceutical companies have a plan to export new drug pipelines and commercialize them. In order to export, transfer and commercialize technology, they have more actively invested funds into R&D.

In particular, some of these pipelines have attracted interests of multinational ‘big pharma.’

Yuhan Corporation have focused on securing more new ...